DNA

Listed Company · UPCOM

Price
26,500
Latest close
03 Apr 2026
P/E 10.4x
EPS (TTM) 2,548
ROE (TTM) 19.1%
P/B 1.7x
BVPS (Latest) 15,364
ROA (TTM) 10.2%

What Is Changing

DNA no longer looks like a business simply rebounding from a weak base. Revenue posted +4.6% YoY, while net margin reached 5.94% with an additional -0.1pp improvement versus the prior year. The next question is whether current profit momentum can hold through the next cycle.

  • Net Income reached a multi-period high at VND 163.5bn in 2025.
Metric 2025 2024 2023 2022 2021
Revenue 2,752.0 2,630.4 2,332.4 2,054.0 1,920.6
Growth +5% +13% +14% +7%
Net Income 163.5 157.6 126.9 114.0 110.9
Net Margin 5.94% 5.99% 5.44% 5.55% 5.78%

Financial Statements

Profitability

Net margin reached 5.94% while Revenue posted +4.6% YoY.

Balance Sheet

Inventory stood at 43.6bn, liabilities at 787.5bn, and equity at 865.5bn.

Cash Flow

Operating cash flow was 268.5bn in 2024, while investing cash flow was -104.4bn.

Financing cash flow: -131.1bn.

Item 2025 2024 2023 2022 2021
Net Revenue
2,752.0 2,630.4 2,332.4 2,054.0 1,920.6
Cost of Goods Sold
2,227.6 2,114.7 1,907.1 1,679.1 0.0
Gross Profit
524.4 515.7 425.4 374.9 345.2
Financial Expenses
20.5 20.2 24.0 25.1 -22.0
Selling Expenses
184.4 176.4 151.6 147.2 -142.2
General and Administrative Expenses
128.3 132.3 106.9 69.3 -69.2
Operating Profit
193.1 189.9 144.8 136.1 117.1
Profit Before Tax
204.4 197.0 157.7 142.7 138.7
Net Income
163.5 157.6 126.9 114.0 110.9
Profit Attributable to Parent
163.5 157.6 126.9 114.0 110.9
Earnings per Share
1,953.00 2,715.00 1,755.00 1,613.00 1,593.00

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.